AUTL insider filings
Autolus Therapeutics plc — 10 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-09-03. Screen AUTL transaction legs live →
Insider transaction summary — last 90 days
2026-07-10 to 2026-10-08, from the filings listed below: 1 insider filing (Forms 3/4/5). Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 1 leg across 1 filing by 1 insider — 6,713 shares, $15,682 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 2.
- Largest priced transaction: sale of 6,713 shares @ $2.34 ($15,682) by Piccina Cintia, filed 2026-09-03.
By insider — same window
Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Insider | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|
| Piccina Cintia — U.S. CCO & Country Gen Manager | 1 | — | 1 leg · 6,713 sh · $15,682 | 2 |
Recent insider filings — Autolus Therapeutics plc
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-03 | 4 | Piccina Cintia — U.S. CCO & Country Gen Manager | Option exercise (M): 20,000 @ $2.35 · Sale (S): 6,713 @ $2.34 · Option exercise (M): 20,000 (derivative) @ $0 | EDGAR |
| 2026-07-01 | 4 | Rao Madduri Ravin — Director | Grant/award (A): 31,667 (derivative) @ $0 · Grant/award (A): 47,500 (derivative) @ $0 | EDGAR |
| 2026-07-01 | 4 | Richardson Ryan — Director | Grant/award (A): 31,667 (derivative) @ $0 · Grant/award (A): 47,500 (derivative) @ $0 | EDGAR |
| 2026-07-01 | 4 | Leiderman Elisabeth — Director | Grant/award (A): 31,667 (derivative) @ $0 · Grant/award (A): 47,500 (derivative) @ $0 | EDGAR |
| 2026-07-01 | 4 | Iannone Robert — Director | Grant/award (A): 31,667 (derivative) @ $0 · Grant/award (A): 47,500 (derivative) @ $0 | EDGAR |
| 2026-07-01 | 4 | Azelby Robert — Director | Grant/award (A): 31,667 (derivative) @ $0 · Grant/award (A): 47,500 (derivative) @ $0 | EDGAR |
| 2026-07-01 | 4 | Bain Linda — Director | Grant/award (A): 31,667 (derivative) @ $0 · Grant/award (A): 47,500 (derivative) @ $0 | EDGAR |
| 2026-07-01 | 4 | BUTITTA CYNTHIA M — Director | Grant/award (A): 31,667 (derivative) @ $0 · Grant/award (A): 47,500 (derivative) @ $0 | EDGAR |
| 2026-07-01 | 4 | BONNEY MICHAEL W — Director | Grant/award (A): 31,667 (derivative) @ $0 · Grant/award (A): 47,500 (derivative) @ $0 | EDGAR |
| 2026-07-01 | 4 | YOUNG WILLIAM D — Director | Grant/award (A): 31,667 (derivative) @ $0 · Grant/award (A): 47,500 (derivative) @ $0 | EDGAR |
Recent 8-K events — Autolus Therapeutics plc
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-11 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-03 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 3.02 — Unregistered Sales of Equity Securities 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-03 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-29 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-06-09 | 8-K | 8.01 — Other Events | EDGAR |
| 2026-05-14 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-29 | 8-K | ? 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-16 | 8-K | 4.01 — Changes in Registrant's Certifying Accountant 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-08 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-27 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=AUTL returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →